BRS2-FM1-PM3 — SAMe Synthesis
Presentation draft — not approved. This copy previews a supported upstream relationship, not an accepted constraint mapping. The canonical PM3 page and its ratings, requirements and mappings are unchanged.
(Producing the Cell's Methyl-Donor Pool)
1. Mission & Overview + Dietary Levers
Mission
Maintain methionine adenosyltransferase capacity to convert methionine and ATP into SAMe, sustaining the methyl-donor pool used by downstream methyltransferases.
Intervention Dominance: Diet-Supported
- Methionine
- Dietary protein
- Methionine
- ATP
- Magnesium ions (Mg²⁺)
- Potassium ions (K⁺)
- One-carbon methyl-donor pool (folate, betaine, choline)
Overview
Methionine adenosyltransferase forms S-adenosylmethionine from methionine and ATP. [1] Magnesium and potassium ions coordinate that ATP-dependent catalysis. [1] [2] This reaction supplies the methyl donor used by many later enzymes. [1] Upstream methionine regeneration and later methyl-transfer reactions remain separate processes. Circulating SAMe and the SAM:SAH ratio describe pool balance rather than synthesis speed. [3]
- Benefits: Forming SAMe provides the common methyl donor used by many different enzymes. [4] Those later uses include DNA methylation, membrane-phospholipid formation, and neurotransmitter metabolism.
- Implementation Notes: Methionine and dietary protein are the provision routes. [1] Magnesium and potassium ions take part in the catalysis and are not separate dosing targets. [1] [2] These reaction requirements do not set an intake for raising SAMe synthesis. [1] [3]
2. Primary Biological Effects
↑ MAT-dependent SAMe formation
↑ availability of the SAMe methyl-donor pool
→ permissive support for downstream methyl-transfer reactions
3. Intervention Levers
1. Food Preparation & Delivery ONLY
- Soak and cook legumes thoroughly where they are used as methionine-containing protein sources.
- Prefer gentle preparation of mixed whole-food protein sources to preserve overall meal quality.
No PM3-specific lifestyle lever is established. General energy metabolism supplies intracellular ATP, but exercise, sleep or timing effects on MAT-dependent SAMe synthesis have not been adjudicated here.
4. Mechanistic Basis
Summary
SAMe production is the point at which methionine and intracellular ATP become a usable methyl donor. The defining event is MAT catalysis; upstream regeneration of methionine and downstream consumption of SAMe determine context but are not part of the synthesis reaction itself.
(Methionine adenosyltransferase reaction)
MAT catalyses an ATP-dependent reaction in which methionine's sulfur attacks ATP's adenosyl carbon to form SAMe; phosphate products are subsequently released. Human MAT2A kinetics support ordered ATP-first, methionine-second binding [1], while human MATα2 structures capture the catalytic states and active-site ion coordination [2].
(Direct requirements and capacity)
Methionine and ATP are reaction substrates. Magnesium and potassium ions participate in active-site phosphate coordination under biochemical and structural conditions [1, 2]. These are biochemical requirements, not evidence that ordinary dietary magnesium, potassium or methionine intake is rate-limiting. MAT isoform abundance, enzyme stability, substrate availability and feedback all contribute to cellular capacity; the reviewed evidence does not establish a simple human basal-versus-reserve dietary threshold.
(Pool state is not synthesis flux)
SAM concentration reflects formation and consumption. The SAM:SAH ratio additionally incorporates SAH production and clearance and is commonly used as a methylation-potential index, not a direct measure of MAT flux. Accurate interpretation also depends on matrix and sample handling because SAM is unstable [3].
(Boundaries of the mechanism)
This PM governs methionine → SAMe formation through MAT. Folate/B12-dependent remethylation belongs to BRS2-FM1-PM1; betaine/BHMT remethylation to BRS2-FM1-PM2; integrated methionine-cycle throughput to BRS2-FM1-PM4; and transsulfuration to BRS2-FM2-PM5. PEMT, DNA, neurotransmitter and other methyl-transfer reactions are downstream consumers, not SAMe synthesis.
(Integration within BRS2)
Within BRS2(FM1) — Methylation Cycle Efficiency, PM1 and PM2 regenerate methionine, PM3 converts it to SAMe, and PM4 represents integrated cycle flux. BRS2(KC2) — Methionine & Transsulfuration Substrate Pool supplies substrate context without proving dietary control of PM3.
4.1 Scientific Findings
Summary
Human MAT structural and kinetic studies converge on the substrates, reaction order and magnesium/potassium coordination involved in SAMe formation. [1] [2] These studies directly establish enzyme mechanism and biochemical requirements. They do not test ordinary dietary modulation, human in-vivo synthesis flux or downstream methylation outcomes, so those effects remain beyond the evidence summarised here.
Human methionine adenosyltransferase (MAT) forms SAMe from methionine and ATP. Catalysis uses coordinated magnesium and potassium ions in the active site, while human MAT2A kinetics indicate ordered ATP-first substrate binding.
What this means
This establishes the biochemical reaction and its direct requirements. It does not establish that increasing dietary methionine, magnesium or potassium increases SAMe synthesis in adequately nourished humans; ATP is an intracellular biochemical substrate, not a dietary lever.
Evidence confidence: Not yet scored
Finding ID: PM3-F1
Finding Statement: MAT-dependent SAMe synthesis directly requires methionine and ATP and uses active-site magnesium and potassium ions to support ATP-dependent catalysis.
Synthesised Evidence Confidence: Not yet scored
Synthesis: Human MAT structural and kinetic studies converge on a defined reaction boundary: MAT catalyses SAMe formation from L-methionine and ATP, with ATP binding before methionine in MAT2A and with divalent magnesium plus potassium coordinating the phosphate chemistry. The studies directly establish enzyme mechanism and substrate/ion requirements. They do not test ordinary dietary modulation, human in-vivo synthesis flux, or downstream methyltransferase outcomes.
Synthesis Limitations: The primary evidence uses purified recombinant protein and crystallised human enzyme rather than intact human physiology. Active-site ion requirements do not show that physiological magnesium or potassium availability ordinarily limits MAT activity. The studies do not establish a methionine intake-response relationship, a clinically meaningful reserve-capacity threshold, or a phenome outcome.
Evidence Considered:
- Study
- Purified recombinant human MAT2A steady-state kinetics, product/dead-end inhibition and isothermal titration calorimetry, with and without MAT2B.
- Population
- Purified human MAT2A/MAT2B proteins; no cells, animals or human participants.
- Result
- ATP bound before methionine; SAM was released before phosphate and pyrophosphate. MAT2B bound tightly and stabilised low-concentration MAT2A but did not significantly change the tested kinetic parameters.
- Effect / Magnitude
- ATP Kd 80 ± 30 μM and Km 50 ± 10 μM; MAT2B Kd 6 ± 1 nM. No significant catalytic-parameter change under saturating MAT2B conditions.
- Evidence Summary
- Direct human-enzyme evidence for the ordered MAT2A reaction and distinction between catalytic activity and MAT2B-mediated stability.
- Limitations
- In-vitro purified-enzyme conditions do not establish in-vivo flux limitation, dietary responsiveness, tissue-specific regulation or phenome effects.
- Evidence Source
- Bounded external search
- Reference
- [1]
- Study
- X-ray crystallography of human MATα2 with methionine, ATP analogues, SAMe, adenosine and phosphate-state ligands.
- Population
- Purified crystallised human MATα2 protein; no cells, animals or human participants.
- Result
- Structures captured methionine repositioning toward ATP C5′, SAMe/product states and phosphate-group coordination by magnesium and potassium ions.
- Effect / Magnitude
- Structures ranged from 1.1 Å to 2.34 Å resolution; no physiological effect size applies.
- Evidence Summary
- Direct structural support for the reaction chemistry and catalytic-ion requirement of human MAT.
- Limitations
- Static ligand-bound structures establish catalytic geometry, not physiological nutrient limitation, in-vivo reaction rate, dietary dose response or clinical outcome.
- Evidence Source
- Bounded external search
- Reference
- [2]
Connected / Supportive Evidence:
- Chiang et al. (1996) [4] — MechanisticWhy relevant: Foundational review establishes SAMe as a major methyl donor and places MAT synthesis upstream of transmethylation.Why excluded from the primary synthesis: It is a broad methylation review and does not independently quantify human MAT kinetics, active-site ion requirements or dietary control of synthesis flux.
- Corrillero Bravo et al. (2022) [3] — Human MechanisticWhy relevant: Measured circulating SAM, SAH and SAM:SAH after contrasting four-week dietary patterns in healthy adults.Why excluded from the primary synthesis: The biomarkers do not isolate MAT synthesis flux; group trajectories were similar, so the study does not establish a dietary lever for PM3.
Informs: Cognitive Clarity; Emotional Regulation
Folate-dependent methionine synthase and betaine-dependent BHMT regenerate methionine from homocysteine. Choline can supply betaine. MAT then uses methionine and ATP to form SAMe.
What this means
This establishes connected precursor provision. It does not make folate, betaine or choline MAT reactants, demonstrate that more intake raises synthesis, or resolve a donor-inadequacy constraint on MAT capacity.
Evidence confidence: Not yet scored
Finding ID: PM3-F4
Finding Statement: Folate and betaine remethylation regenerate methionine upstream of MAT-dependent SAMe formation; choline can contribute through betaine.
Synthesised Evidence Confidence: Not yet scored
Synthesis: Existing reviewed PM1-F1, PM2-F1/PM2-F2 and PM3-F1 establish the successive reaction identities. Folate provides 5-methyltetrahydrofolate for B12-dependent methionine synthase, while betaine supplies the alternative BHMT reaction, predominantly in liver and kidney. Choline oxidation can supply betaine. The regenerated methionine is available to the MAT reaction. Evidence supports the route, without requiring each donor to act directly on MAT.
Synthesis Limitations: Tissue expression, alternative methionine supply and pathway compensation limit generalisation. SAMe and SAM:SAH are pool-state measurements rather than isolated synthesis rates. No established limiting effect on MAT capacity or nutrient-replete intake benefit is claimed.
Evidence Considered:
- Froese et al. (2019) — Mechanistic — Establishes folate/B12 remethylation and placement before MAT synthesis; reviewed on PM1-F1.
- Obeid (2013) — Mechanistic — Establishes betaine donation and choline provision in connected remethylation; reviewed on PM2-F1/F2.
- Bailey et al. (2021) — Mechanistic — Establishes methionine and ATP use in human MAT2A; reviewed on PM3-F1.
5. BRS Pathways and Connections
5.1 BRS Pathways
BRS2-FM1-PM1 — Folate/B12-Dependent Homocysteine Remethylation / BRS2-FM1-PM2 — Betaine/BHMT Remethylation
↓
BRS2-FM1-PM3 — SAMe Synthesis
↓
BRS2-FM1-PM4 — Methionine Cycle Flux
5.2 Cross-BRS Mechanism Relationships
- None listed
5.3 Local BRS Mechanism Relationships
- BRS2-FM1-PM1 — Folate/B12-Dependent Homocysteine Remethylation — Remethylates homocysteine to methionine that can enter SAM synthesis. Upstream methionine supply, not the MAT step itself.
- BRS2-FM1-PM2 — Betaine/BHMT Remethylation — Alternative remethylation route to methionine. Parallel supply, not SAM synthetase activity.
- BRS2-FM1-PM4 — Methionine Cycle Flux — Consumes and regenerates methionine around SAM-using reactions. Shared one-carbon resource, not this PM’s synthesis reaction.
7. Phenome Connections
These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework.
Each Phenome relationship has two independent ratings. They are not combined or averaged.
Biology → Phenome Relationship Strength
How direct and important is this biological mechanism expected to be to the Phenome within the BRAIN model?
Evidence Confidence
How strongly does the adjudicated evidence support this particular biology → Phenome relationship?
- Biology → Phenome Relationship Strength: Medium
- Evidence Confidence: Low–Medium
- Rationale: SAMe supplies methyl groups used by many downstream pathways relevant to neural function, but this is an inferred downstream bridge rather than evidence that MAT-dependent SAMe synthesis itself modulates Cognitive Clarity. The attached methylation review establishes SAMe's donor role, not a cognitive outcome or endogenous synthesis-flux effect Chiang et al. (1996) [4]. Circulating SAMe or SAM:SAH measurements cannot isolate MAT synthesis from utilisation and clearance Corrillero Bravo et al. (2022) [3]. Direct relationship evidence remains a gap.
Supporting evidence
SAMe supplies methyl groups to many neural pathways, but the attached evidence does not directly connect MAT-dependent SAMe synthesis capacity with Cognitive Clarity.
What this means
General dependence of cognition-relevant pathways on methyl donors must not be presented as direct phenome evidence for PM3.
Evidence confidence: Not yet scored
Finding ID: PM3-F3
Finding Statement: The repository-attached methylation evidence establishes SAMe's donor role but does not directly demonstrate that endogenous MAT-dependent SAMe synthesis capacity modulates Cognitive Clarity.
Synthesised Evidence Confidence: Not yet scored
Synthesis: The foundational review establishes SAMe as a central methyl donor used in numerous downstream reactions. That broad biochemical role supports plausibility but does not isolate MAT synthesis capacity, measure cognitive clarity, or show that changing synthesis flux changes a cognitive outcome. The PM3-to-Cognitive Clarity relationship therefore remains a mechanistic inference with a direct-evidence gap.
Synthesis Limitations: This conclusion is bounded to the attached corpus plus targeted construct clarification. It does not exclude cognitive consequences in severe inherited disorders or downstream methylation studies; those contexts would not by themselves establish ordinary PM3 modulation.
Evidence Considered:
- Chiang et al. (1996) [4] — Mechanistic — Establishes SAMe as a principal methyl donor across downstream chemistry but does not measure Cognitive Clarity or endogenous MAT synthesis flux.
Informs: Cognitive Clarity
- Biology → Phenome Relationship Strength: Low–Medium
- Evidence Confidence: Low
- Rationale: SAMe-dependent methylation is biologically relevant to downstream neurotransmitter and membrane chemistry, but the attached mood-disorder review concerns exogenous SAMe and combined folate/B12 treatment rather than endogenous MAT activity or SAMe synthesis flux Cicero and Minervino (2022) [5]. It therefore does not directly demonstrate that this PM modulates Emotional Regulation; the relationship remains an indirect framework bridge with a direct-evidence gap.
Supporting evidence
The attached clinical literature discusses exogenous SAMe, folate and vitamin B12 in mood disorders. That intervention context does not test whether endogenous methionine-to-SAMe synthesis through MAT modulates emotional regulation.
What this means
The Emotional Regulation relationship is biologically plausible downstream of methyl-donor chemistry but remains indirect for this PM.
Evidence confidence: Not yet scored
Finding ID: PM3-F2
Finding Statement: The repository-attached mood-disorder evidence does not directly demonstrate an effect of endogenous MAT-dependent SAMe synthesis capacity on Emotional Regulation.
Synthesised Evidence Confidence: Not yet scored
Synthesis: The attached review supports clinical interest in administered SAMe and combined one-carbon nutrients for mood disorders, but its intervention construct is exogenous treatment and its outcomes are mood symptoms. It does not manipulate MAT, quantify endogenous SAMe synthesis flux, or isolate PM3 from upstream folate/B12 remethylation and downstream methyltransferase biology. The PM3-to-Emotional Regulation proposition is therefore an inferred downstream bridge rather than a directly demonstrated relationship.
Synthesis Limitations: This is an adjudicated gap within the bounded attached corpus, not proof that no relationship exists. The source is a narrative clinical review, mixes interventions and pathway levels, and does not provide a PM3-specific causal test.
Evidence Considered:
- Cicero and Minervino (2022) [5] — Human Outcome — Reviews exogenous SAMe with folate/B12 in mood-disorder treatment but does not measure MAT activity or endogenous SAMe synthesis flux.
Informs: Emotional Regulation
8. References
-
[1] Bailey et al. (2021) — Human MAT2A ordered kinetic mechanism
-
[3] Corrillero Bravo et al. (2022) — SAM and SAH measurement and dietary intervention
-
[4] Chiang et al. (1996) — S-Adenosylmethionine and methylation
-
[5] Cicero and Minervino (2022) — SAMe, folate and B12 in mood disorders
-
[7] Froese et al. (2019) — Vitamin B12, Folate and Methionine Remethylation
-
[8] Obeid (2013) — Metabolic Burden of Methyl Donor Deficiency